Who owns MIST?
Institutional ownership of Milestone Pharmaceuticals Inc. from Form 13F, Q2 2026
78 institutional managers reported holding Milestone Pharmaceuticals Inc. (MIST) in Form 13F filings for Q2 2026, with 50,837,200 shares worth $68.1M. The largest reported holder was Pavaki Capital Management LLC. Managers that filed both quarters added a net 12,001,014 shares (+40.3%). 7 opened new positions and 13 sold out.
- Funds holding
- 78
- Value held
- $68.1M
- New / sold out
- 7 / 13
- Net shares, same filers
- +40.3%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of MIST
Share of 13F holdings is each fund's shares as a share of the 50,837,200 MIST shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Point72 Asset Management, L.P. Added+$5.8M
- Propel Bio Management, LLC Added+$4.4M
- Kalehua Capital Management LLC New+$3.4M
- Simplify Asset Management Inc. Added+$2.5M
- Millennium Management LLC Added+$2.1M
- RTW Investments, LP Added+$2.0M
- Ameriprise Financial Inc New+$893K
- Boothbay Fund Management, LLC Added+$394K
- Wealthspire Advisors, LLC Added+$174K
- Cascades Capital Asset Management, LLC New+$112K
Biggest sellers in Q2 2026
- Goldman Sachs Group Inc Sold out-$2.4M
- Balyasny Asset Management L.P. Trimmed-$845K
- Two Sigma Investments, LP Trimmed-$371K
- Citadel Advisors LLC Trimmed-$220K
- Susquehanna International Group, LLP Trimmed-$213K
- Marshall Wace, LLP Trimmed-$197K
- Group One Trading LLC Trimmed-$173K
- Renaissance Technologies LLC Sold out-$154K
- Squarepoint Ops LLC Trimmed-$141K
- Jane Street Group, LLC Trimmed-$137K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $22.2M and sold $5.8M; 22 added and 23 trimmed.
Schedule 13D and 13G filings on MIST
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-07-21Trails Edge Capital Partners, LP SCHEDULE 13G filed by Milestone Pharmaceuticals Inc.Schedule 13G
Questions about MIST ownership
- Who owns MIST stock?
- 78 institutional investment managers reported MIST positions in their Form 13F filings for Q2 2026, holding 50,837,200 shares worth $68.1M in total. Pavaki Capital Management LLC reported the largest position.
- Are funds buying or selling MIST?
- In Q2 2026, 7 managers opened new MIST positions, 22 added, 23 trimmed and 13 sold out. Managers that filed in both quarters added a net 12,001,014 shares.
- How current is this MIST institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to MIST by CUSIP. Options are left out. MIST news and filings · MIST insider trades · Top funds